All In Biotech

Drug Trial Radar · NCT01421693

Gatifloxacin Versus Ceftriaxone in the Treatment of Enteric Fever

Randomized, Open-label, Superiority Trial of the Effectiveness of Gatifloxacin Versus Ceftriaxone for the Treatment of Uncomplicated Enteric Fever.

Last checked: Nov 20, 2026Latest source record: Oct 4, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 300 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

300

Actual

Start

Sep 2011

Primary completion

Jul 2014

Study completion Jan 2015

Sponsor

Lead sponsor
Oxford University Clinical Research Unit, VietnamAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
University of Oxford; Patan Academy of Health Sciences, Nepal; Patan Hospital, Nepal; Civil Hospital, Nepal
First posted
Aug 23, 2011

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 2 years, up to 45 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The investigators aim to compare two antibiotic treatments for enteric (typhoid) fever. Three hundred patients at Patan Hospital will be enrolled in the study. Patients will be assigned to one of the two treatments by chance and followed for 6 months. The two treatment groups will be compared to see which treatment is more likely to make the patient better.

Conditions

  • Enteric Fever
  • Typhoid Fever

Interventions

  • CeftriaxoneDrug

    * ≥2-\<14 years - 60mg/kg/ once daily for 7 days * 14 years and older - 2g once daily for 7 days * Intravenous infusion. Vials of crystalline powder.

  • GatifloxacinDrug

    Gatifloxacin 10 mg/kg/day for 7 days. Tablets for oral administration.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Rate of treatment failureTime frame: upon occurance, within 28 days

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Civil Hospital

    Kathmandu, Nepal

  • Patan Hospital

    Kathmandu, Nepal

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.